Works by Sullivan, Daniel M.

Results: 29

The absolute bioavailability of oral vinorelbine in patients with solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 578, doi. 10.1007/s00280-005-1025-0

By:

Lush, Richard M.;
McCune, Jeannine S.;
Tetteh, Leticia;
Thompson, John A.;
Mahany, J. J.;
Garland, Linda;
Suttle, A. Benjamin;
Sullivan, Daniel M.

Publication type:

Article

Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironment.

Published in:

Cancer Biology & Therapy, 2016, v. 17, n. 5, p. 477, doi. 10.1080/15384047.2016.1156261

By:

Pisklakova, Alexandra;
Grigson, Eileen;
Ozerova, Maria;
Chen, Feng;
Sullivan, Daniel M.;
Nefedova, Yulia

Publication type:

Article

Identification and characterization of P2Y<sub>2</sub> nucleotide receptors in human retinal pigment epithelial cells.

Published in:

Journal of Neuroscience Research, 1997, v. 49, n. 1, p. 43, doi. 10.1002/(SICI)1097-4547(19970701)49:1<43::AID-JNR5>3.0.CO;2-D

By:

Sullivan, Daniel M.;
Erb, Lauri;
Anglade, Eddy;
Weisman, Gary A.;
Turner, John T.;
Csaky, Karl G.

Publication type:

Article

Phase II study of pegylated liposomal doxorubicin, low-dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma.

Published in:

American Journal of Hematology, 2014, v. 89, n. 1, p. 62, doi. 10.1002/ajh.23587

By:

Baz, Rachid C.;
Shain, Kenneth H.;
Hussein, Mohamad A.;
Lee, Ji-Hyun;
Sullivan, Daniel M.;
Oliver, Elizabeth Finley;
Nardelli, Lisa A.;
Nodzon, Lisa A.;
Zhao, Xiuhua;
Ochoa-Bayona, Jose Leonel;
Nishihori, Taiga;
Dalton, William S.;
Alsina, Melissa

Publication type:

Article

Rapid Screening of Novel Agents for Combination Therapy in Sarcomas.

Published in:

2013

By:

Cubitt, Christopher L.;
Menth, Jiliana;
Dawson, Jana;
Martinez, Gary V.;
Foroutan, Parastou;
Morse, David L.;
Bui, MarilynM.;
Letson, G. Douglas;
Sullivan, Daniel M.;
Reed, Damon R.

Publication type:

Journal Article

Rapid Screening of Novel Agents for Combination Therapy in Sarcomas.

Published in:

Sarcoma, 2013, p. 1, doi. 10.1155/2013/365723

By:

Cubitt, Christopher L.;
Menth, Jiliana;
Dawson, Jana;
Martinez, Gary V.;
Foroutan, Parastou;
Morse, David L.;
Bui, MarilynM.;
Letson, G. Douglas;
Sullivan, Daniel M.;
Reed, Damon R.

Publication type:

Article

Long-term intravenous hydroxyurea infusions in patients with advanced cancer. A phase I trial.

Published in:

1993

By:

Blumenreich, Martin S.;
Kellihan, Michael J.;
Joseph, U. Geetha;
Lalley, Kim A.;
Sherrill, Eliza J.;
Sullivan, Daniel M.;
Hamm, John T.;
Gentile, Patrick S.;
Sheth, Subash P.;
Seeger, Janell;
Woodcock, Thomas M.;
Blumenreich, M S;
Kellihan, M J;
Joseph, U G;
Lalley, K A;
Sherrill, E J;
Sullivan, D M;
Hamm, J T;
Gentile, P S;
Sheth, S P

Publication type:

journal article

Implementation of Timeline Reforms Speeds Initiation of National Cancer Institute-Sponsored Trials.

Published in:

JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 13, p. 954, doi. 10.1093/jnci/djt137

By:

Abrams, Jeffrey S.;
Mooney, Margaret M.;
Zwiebel, James A.;
Kern, Edward L.;
Friedman, Steven H.;
Finnigan, Shanda R.;
Schettino, Patricia R.;
Denicoff, Andrea M.;
Kruhm, Martha G.;
Montello, Mike;
Misra, R. Rita;
Ansher, Sherry S.;
DiPiazza, Kate J.;
Souhan, Erin M.;
Wickerham, D. Lawrence;
Giantonio, Bruce J.;
O'Donnell, Robert T.;
Sullivan, Daniel M.;
Soto, Nancy I.;
Fleming, Gini F.

Publication type:

Article

Cover Picture: Chem. Eur. J. 17/2002.

Published in:

Chemistry - A European Journal, 2002, v. 8, n. 17, p. 3819, doi. 10.1002/1521-3765(20020902)8:17<3819::AID-CHEM3819>3.0.CO;2-7

By:

Bruening, Merlin L.;
Sullivan, Daniel M.

Publication type:

Article

Enhancing the Ion-Transport Selectivity of Multilayer Polyelectrolyte Membranes.

Published in:

Chemistry - A European Journal, 2002, v. 8, n. 17, p. 3832, doi. 10.1002/1521-3765(20020902)8:17<3832::AID-CHEM3832>3.0.CO;2-8

By:

Bruening, Merlin L.;
Sullivan, Daniel M.

Publication type:

Article

Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies.

Published in:

Cancer Medicine, 2016, v. 5, n. 2, p. 294, doi. 10.1002/cam4.598

By:

Reed, Damon R.;
Mascarenhas, Leo;
Manning, Kathleen;
Hale, Gregory A.;
Goldberg, John;
Gill, Jonathan;
Sandler, Eric;
Isakoff, Michael S.;
Smith, Tiffany;
Caracciolo, Jamie;
Lush, Richard M.;
Juan, Tzu‐Hua;
Lee, Jae K.;
Neuger, Anthony M.;
Sullivan, Daniel M.

Publication type:

Article

Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance.

Published in:

International Journal of Cancer, 1996, v. 66, n. 4, p. 520, doi. 10.1002/(SICI)1097-0215(19960516)66:4<520::AID-IJC16>3.0.CO;2-B

By:

Futscher, Bernard W.;
Foley, Nils E.;
Gleason-Guzman, Mary C.;
Meltzer, Paul S.;
Sullivan, Daniel M.;
Dalton, William S.

Publication type:

Article

Spending and Job-Finding Impacts of Expanded Unemployment Benefits: Evidence from Administrative Micro Data.

Published in:

American Economic Review, 2024, v. 114, n. 9, p. 2898, doi. 10.1257/aer.20220973

By:

Ganong, Peter;
Greig, Fiona;
Noel, Pascal;
Sullivan, Daniel M.;
Vavra, Joseph

Publication type:

Article

State-of-the-Art Management of Complications of Myeloma and Its Treatment.

Published in:

Advances in Hematology, 2010, v. 2010, p. 1, doi. 10.1155/2010/343089

By:

Hartley-Brown, Monique A.;
Sullivan, Daniel M.;
Baz, Rachid

Publication type:

Article

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.

Published in:

Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-1

By:

Rhoda Molife, L.;
Li Yan;
Vitfell-Rasmussen, Joanna;
Zernhelt, Adriane M.;
Sullivan, Daniel M.;
Cassier, Philippe A.;
Eric Chen;
Biondo, Andrea;
Tetteh, Ernestina;
Siu, Lillian L.;
Patnaik, Amita;
Papadopoulos, Kyriakos P.;
De Bono, Johann S.;
Tolcher, Anthony W.;
Minton, Susan

Publication type:

Article

Lenalidomide‐based response‐adapted therapy for older adults without high risk myeloma.

Published in:

British Journal of Haematology, 2019, v. 184, n. 5, p. 735, doi. 10.1111/bjh.15700

By:

Baz, Rachid;
Naqvi, Syeda Mahrukh Hussnain;
Lee, Jae‐Hoon;
Brayer, Jason;
Hillgruber, Nancy;
Fridley, Brooke L.;
Shain, Kenneth H.;
Sullivan, Daniel M.;
Alsina, Melissa

Publication type:

Article

Bortezomib salvage followed by a Phase I/ II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma.

Published in:

British Journal of Haematology, 2012, v. 157, n. 5, p. 553, doi. 10.1111/j.1365-2141.2012.09099.x

By:

Nishihori, Taiga;
Alekshun, Todd J.;
Shain, Kenneth;
Sullivan, Daniel M.;
Baz, Rachid;
Perez, Lia;
Pidala, Joseph;
Kharfan-Dabaja, Mohamed A.;
Ochoa-Bayona, Jose L.;
Fernandez, Hugo F.;
Yarde, Danielle N.;
Oliveira, Vasco;
Fulp, William;
Han, Gang;
Kim, Jongphil;
Chen, Dung-Tsa;
Raychaudhuri, Jyoti;
Dalton, William;
Anasetti, Claudio;
Alsina, Melissa

Publication type:

Article

Effect of Age on Clinical Outcomes in Phase 1 Trial Participants.

Published in:

Cancer Control: Journal of the Moffitt Cancer Center, 2015, v. 22, n. 2, p. 235, doi. 10.1177/107327481502200217

By:

Mahipal, Amit;
Denson, Aaron C.;
Djulbegovic, Benjamin;
Lush, Richard;
Kumar, Ambuj;
Tzu-Hua Juan;
Schell, Michael J.;
Sullivan, Daniel M.

Publication type:

Article

Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.

Published in:

Journal of Cellular Biochemistry, 2004, v. 92, n. 2, p. 223, doi. 10.1002/jcb.20045

By:

Douglas C. Marchion;
Elona Bicaku;
Adil I. Daud;
Victoria Richon;
Daniel M. Sullivan;
Pamela N. Munster

Publication type:

Article

Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIα and β in various human cancer cell lines.

Published in:

Journal of Cellular Biochemistry, 1999, v. 75, n. 2, p. 245, doi. 10.1002/(SICI)1097-4644(19991101)75:2<245::AID-JCB7>3.0.CO;2-G

By:

Hochhauser, Daniel;
Valkov, Nikola I.;
Gump, Jana L.;
Wei, Irene;
O'Hare, Carolyn;
Hartley, John;
Fan, Jianguo;
Bertino, Joseph R.;
Banerjee, Debabrata;
Sullivan, Daniel M.

Publication type:

Article

Quantitative immunofluorescence and immunoelectron microscopy of the topoisomerase IIα associated with nuclear matrices from wild-type and drug-resistant Chinese hamster ovary cell lines.

Published in:

Journal of Cellular Biochemistry, 1997, v. 67, n. 1, p. 112, doi. 10.1002/(SICI)1097-4644(19971001)67:1<112::AID-JCB12>3.0.CO;2-J

By:

Valkov, Nikola I.;
Gump, Jana L.;
Sullivan, Daniel M.

Publication type:

Article

Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma.

Published in:

Scientific Reports, 2015, p. 16991, doi. 10.1038/srep16991

By:

Yu, Diana;
Kahen, Elliot;
Cubitt, Christopher L.;
McGuire, Jeremy;
Kreahling, Jenny;
Lee, Jae;
Altiok, Soner;
Lynch, Conor C.;
Sullivan, Daniel M.;
Reed, Damon R.

Publication type:

Article

Canonical Wnt Pathway Inhibitor ICG-001 Induces Cytotoxicity of Multiple Myeloma Cells in Wnt-Independent Manner.

Published in:

PLoS ONE, 2015, v. 10, n. 1, p. 1, doi. 10.1371/journal.pone.0117693

By:

Grigson, Eileen R.;
Ozerova, Maria;
Pisklakova, Alexandra;
Liu, Hao;
Sullivan, Daniel M.;
Nefedova, Yulia

Publication type:

Article

A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.

Published in:

Oncologist, 2016, v. 21, n. 10, p. 1163, doi. 10.1634/theoncologist.2016-0220

By:

Chiappori, Alberto A.;
Otterson, Gregory A.;
Dowlati, Afshin;
Traynor, Anne M.;
Horn, Leora;
Owonikoko, Taofeek K.;
Ross, Helen J.;
Hann, Christine L.;
Abu Hejleh, Taher;
Nieva, Jorge;
Zhao, Xiuhua;
Schell, Michael;
Sullivan, Daniel M.

Publication type:

Article

Lawyers Steer Clients Toward Lucrative Filings: Evidence from Consumer Bankruptcies.

Published in:

American Law & Economics Review, 2015, v. 17, n. 1, p. 245, doi. 10.1093/aler/ahv004

By:

McIntyre, Frank;
Sullivan, Daniel M.;
Summers, Laura

Publication type:

Article

Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors.

Published in:

Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0304-z

By:

Turner, Joel G.;
Dawson, Jana L.;
Grant, Steven;
Shain, Kenneth H.;
Dalton, William S.;
Yun Dai;
Meads, Mark;
Baz, Rachid;
Kauffman, Michael;
Shacham, Sharon;
Sullivan, Daniel M.

Publication type:

Article

A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors.

Published in:

Breast Cancer Research, 2013, v. 15, n. 6, p. 3, doi. 10.1186/bcr3577

By:

Hudis, Clifford;
Swanton, Charles;
Janjigian, Yelena Y.;
Lee, Ray;
Sutherland, Stephanie;
Lehman, Robert;
Chandarlapaty, Sarat;
Hamilton, Nicola;
Gajria, Devika;
Knowles, James;
Shah, Jigna;
Shannon, Keith;
Tetteh, Ernestina;
Sullivan, Daniel M.;
Moreno, Carolina;
Yan, Li;
Han, Hyo Sook

Publication type:

Article

A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors.

Published in:

2013

By:

Hudis, Clifford;
Swanton, Charles;
Janjigian, Yelena Y;
Lee, Ray;
Sutherland, Stephanie;
Lehman, Robert;
Chandarlapaty, Sarat;
Hamilton, Nicola;
Gajria, Devika;
Knowles, James;
Shah, Jigna;
Shannon, Keith;
Tetteh, Ernestina;
Sullivan, Daniel M;
Moreno, Carolina;
Yan, Li;
Han, Hyo;
Han, Hyo Sook

Publication type:

journal article

Cell density-dependent VP-16 sensitivity of leukaemic cells is accompanied by the translocation of topoisomerase IIα from the nucleus to the cytoplasm.

Published in:

British Journal of Haematology, 2000, v. 108, n. 2, p. 331, doi. 10.1046/j.1365-2141.2000.01832.x

By:

Valkov;
Gump;
Engel;
Sullivan;
M. Sullivan, Daniel

Publication type:

Article